Page last updated: 2024-08-23

androstane-3,17-diol and Invasiveness, Neoplasm

androstane-3,17-diol has been researched along with Invasiveness, Neoplasm in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Biserni, A; Caruso, D; Ciana, P; Della Torre, S; Dondi, D; Locatelli, A; Maggi, A; Piccolella, M; Poletti, A; Ramachandran, B; Rusmini, P; Sau, D	1

Other Studies

1 other study(ies) available for androstane-3,17-diol and Invasiveness, Neoplasm

Article	Year
Estrogen receptor beta and the progression of prostate cancer: role of 5alpha-androstane-3beta,17beta-diol. Endocrine-related cancer, 2010, Volume: 17, Issue:3 Topics: Anabolic Agents; Androstane-3,17-diol; Animals; Apoptosis; Blotting, Western; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Collagen; Drug Combinations; Estrogen Receptor beta; Humans; Laminin; Male; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Prostatic Neoplasms; Proteoglycans; Receptors, Androgen; Survival Rate; Xenograft Model Antitumor Assays	2010

Article

Year

Estrogen receptor beta and the progression of prostate cancer: role of 5alpha-androstane-3beta,17beta-diol.

Endocrine-related cancer, 2010, Volume: 17, Issue:3

Topics: Anabolic Agents; Androstane-3,17-diol; Animals; Apoptosis; Blotting, Western; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Collagen; Drug Combinations; Estrogen Receptor beta; Humans; Laminin; Male; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Prostatic Neoplasms; Proteoglycans; Receptors, Androgen; Survival Rate; Xenograft Model Antitumor Assays

2010